HIF1A and neoplasm: In the present study, the expression of HIF-1α and its downstream targets VEGF-A, COX-2, VEGF-R2, and iNOS [24] were reduced in tumor tissue treated with HEGU or licoricidin (Figure 1C and Figure 4A).